Eukaryotic translation initiation factor 3 subunit I pseudogene 2 (EIF3IP2)

EIF3IP2 (eukaryotic translation initiation factor 3 subunit I pseudogene 2) is a pseudogene derived from the functional EIF3I gene, which encodes a subunit of the eukaryotic translation initiation factor 3 (eIF3) complex. Unlike its parent gene (EIF3I), which is involved in mRNA translation, cell proliferation, and cancer biology[1][4], EIF3IP2 does not encode a functional protein and currently has no established biological activity or therapeutic relevance. Additional context: EIF3I, the parent gene, is a protein-coding gene and part of the eIF3 multiprotein complex, which plays a central role in initiating translation and is implicated in cancer and cell cycle regulation[1][2][3][4]. However, information for EIF3IP2 itself is limited to its classification as a pseudogene. Pseudogenes do not produce functional proteins and generally do not serve as therapeutic targets, interact with drugs, or have biomarkers or safety concerns associated with them. Summary of error: Queries referring to EIF3IP2 as a therapeutic target, receptor, or molecular tool are incorrect. In research and drug development databases, only the active gene or protein (EIF3I, not EIF3IP2) is relevant to disease associations or as a drug target[1][4].

Other names

EIF3IP2eukaryotic translation initiation factor 3 subunit I pseudogene 2EIF3I pseudogene 2